Open original FDA record ↗Recall record
- FDA identifier
- Z-0301-2027
- Company in FDA record
- BioMerieux SA
- FDA classification date
- Oct 27, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Delayed or no result when analyzing clinical samples with EMAG system (ref: 418591/418591U) due to a randomly occurring software error, Error 10003 Heater timeout after updating to recent firmware SP4 Patch 2
Source facts
- Action
- The firm began notifying consignees on September 11, 2026. Customers were informed they may continue use of EMAG systems and there is no risk of false results. In case of 10003 error heater time-out during an extraction protocol, customers are instructed to reset the system to run the protocol again to prevent delay/loss of sample. The company will contact customers to schedule a bioMerieux Field Service Engineer (FSE) visit to update affected EMAG systems to the previous firmware patch SP4 Patch 1 to fix the issue.
- Initiated
- 2026-09-11
- Root cause
- Software change control
- Distribution
- Worldwide - US Nationwide distribution in the states of CA, IN, KS, LA, MN, MO, NY, OH, and TX. The countries of Canada, United Kingdom, Sweden, France, Norway, Netherlands, Belgium, Denmark, Germany, Austria.
- Recall number
- Z-0301-2027
- Recall status
- Open, Classified
- CDRH record ID
- 222883
- FDA classified
- 2026-10-27
- Recall event number
- 99931